Literature DB >> 17194814

The construct of generalized anxiety disorder in Alzheimer disease.

Sergio E Starkstein1, Ricardo Jorge, Gustavo Petracca, Robert G Robinson.   

Abstract

OBJECTIVES: The objectives of this study were to examine the criterion validity in Alzheimer disease (AD) of Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) and the International Classification of Diseases, 10th Revision (ICD-10) criteria for generalized anxiety disorder (GAD), to clarify the symptoms associated with excessive anxiety and worry in AD, to examine the co-occurrence of GAD and depression in these patients, and to determine the neuropsychologic and functional impact of GAD in AD.
RESULTS: One hundred forty-four of a consecutive series of 552 patients with probable AD (26%) reported excessive anxiety and worry difficult to control for most of the 6 months before the psychiatric evaluation. Excessive anxiety and worry were significantly associated with restlessness, irritability, muscle tension, fears, and respiratory symptoms of anxiety. Using these symptoms as diagnostic criteria, 56 of the 552 patients (10%) met revised diagnostic criteria for GAD as compared with 15% when using DSM-IV criteria and 9% when using the ICD-10 criteria. GAD was present in 38 of the 144 patients (26%) with major depression and in 12 of the 261 patients (5%) without depression. Patients with both GAD and depression showed more severe cognitive deficits than patients with either GAD or depression only.
CONCLUSION: The authors validated a set of diagnostic criteria for anxiety in dementia. These criteria include restlessness, irritability, muscle tension, fears, and respiratory symptoms in the context of excessive anxiety and worry. Anxiety in AD is a frequent comorbid condition of major depression.

Entities:  

Mesh:

Year:  2007        PMID: 17194814     DOI: 10.1097/01.JGP.0000229664.11306.b9

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  21 in total

1.  Characteristics of generalized anxiety disorder in patients with dementia.

Authors:  Jessica S Calleo; Mark E Kunik; Dana Reid; Cynthia Kraus-Schuman; Amber Paukert; Tziona Regev; Nancy Wilson; Nancy J Petersen; A Lynn Snow; Melinda Stanley
Journal:  Am J Alzheimers Dis Other Demen       Date:  2011-11-07       Impact factor: 2.035

Review 2.  Improving recognition of late life anxiety disorders in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition: observations and recommendations of the Advisory Committee to the Lifespan Disorders Work Group.

Authors:  Jan Mohlman; Christina Bryant; Eric J Lenze; Melinda A Stanley; Amber Gum; Alastair Flint; Aartjan T F Beekman; Julie Loebach Wetherell; Steven R Thorp; Michelle G Craske
Journal:  Int J Geriatr Psychiatry       Date:  2011-07-20       Impact factor: 3.485

3.  Intracranial IL-17A overexpression decreases cerebral amyloid angiopathy by upregulation of ABCA1 in an animal model of Alzheimer's disease.

Authors:  Junling Yang; Jinghong Kou; Robert Lalonde; Ken-Ichiro Fukuchi
Journal:  Brain Behav Immun       Date:  2017-05-17       Impact factor: 7.217

4.  Treatment outcomes of a crisis intervention program for dementia with severe psychiatric complications: the Kansas bridge project.

Authors:  David Kevin Johnson; Michelle Niedens; Jessica R Wilson; Lora Swartzendruber; Amy Yeager; Kelly Jones
Journal:  Gerontologist       Date:  2012-08-30

5.  Anxiety and stigma in dementia: a threat to aging in place.

Authors:  Rebecca J Riley; Sandy Burgener; Kathleen C Buckwalter
Journal:  Nurs Clin North Am       Date:  2014-06       Impact factor: 1.208

6.  Cognitive and neuropsychiatric impairments in Alzheimer's disease: current treatment strategies.

Authors:  Anna Borisovskaya; Marcella Pascualy; Soo Borson
Journal:  Curr Psychiatry Rep       Date:  2014-09       Impact factor: 5.285

7.  Pharmacological Management of Anxiety Disorders in the Elderly.

Authors:  Elizabeth A Crocco; Sindy Jaramillo; Caroline Cruz-Ortiz; Katherine Camfield
Journal:  Curr Treat Options Psychiatry       Date:  2017-02-10

8.  Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice.

Authors:  Anbrin Masood; Ahmed Nadeem; S Jamal Mustafa; James M O'Donnell
Journal:  J Pharmacol Exp Ther       Date:  2008-05-02       Impact factor: 4.030

Review 9.  Towards defining restlessness in individuals with dementia.

Authors:  Natalie G Regier; Laura N Gitlin
Journal:  Aging Ment Health       Date:  2016-01-08       Impact factor: 3.658

10.  Anxiety disorders in older adults: looking to DSM5 and beyond...

Authors:  Christina Bryant; Jan Mohlman; Amber Gum; Melinda Stanley; Aartjan T F Beekman; Julie Loebach Wetherell; Steven R Thorp; Alastair J Flint; Eric J Lenze
Journal:  Am J Geriatr Psychiatry       Date:  2013-02-06       Impact factor: 4.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.